Glycaemic control and the risk of mortality in elderly type 2 diabetic patients (ZODIAC-20)

International Journal of Clinical Practice

Volumn 65, Issue 4, 2011, Pages 415-419

  Van Hateren, Kornelis J J ^a   Landman, G W D ^a   Kleefstra, N ^a,b,c   Drion, I ^a   Groenier, K H ^c   Houweling, S T ^b,c,d   Bilo, H J G ^a,c  

^a ISALA HOSPITAL   (Netherlands)

^b LANGERHANS MEDICAL RESEARCH GROUP   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d General Practice Sleeuwijk ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE DURATION; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CAUSE OF DEATH; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 79952759745     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02596.x     Document Type: Article

References (13)

1. Emanuele NV. Duration of diabetes, glucose control and cardiovascular risk. Diabetologia 2010; 53: 214-5.
2. Turnbull FM, Abraira C, Anderson RJ et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009; 52: 2288-98.
3. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-89.
4. The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008; 358: 2545-59.
5. The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560-72.
6. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129-39.
7. Stettler C, Allemann S, Jüni P et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J 2006; 152: 27-38. (Pubitemid 43974725)
8. American Diabetes Association. Standard of medical care in diabetes - 2010. Diabetes Care 2010; 33: S11-61.
9. Ubink-Veltmaat LJ, Bilo HJG, Groenier KH, Rischen RO, Meyboom-de Jong B. Shared care with task delegation to nurses for type 2 diabetes, a prospective observational study. Neth J Med 2005; 63: 103-10. (Pubitemid 40403411)
10. Adler AI, Stratton IM, Neil HAW et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-9. (Pubitemid 30609443)
11. Natarajan S, Lipsitz SR, Rimm E. A simple method of determining confidence intervals for population attributable risk from complex surveys. Stat Med 2007; 26: 3229-39. (Pubitemid 47039783)
12. Currie CJ, Peters JR, Tynan A et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective study. Lancet 2010; 375: 481-9.
13. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformine on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854-65.